SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Novo Nordisk CEO Says Wegovy Pill Captures 80% of New Oral Starts

The CEO said Wegovy’s pill is still capturing around 80% of new oral patient starts.

Related stories